BC Innovations | May 26, 2016
Distillery Techniques

Techniques: Plasma and urine levels of heparan sulfate 6-O-sulfotransferase 2 (HS6ST2), chondroitin polymerizing factor 2 (CHPF2) and exostosin-like glycosyltra

Biomarkers TECHNOLOGY: Diagnostic assays A method of scoring plasma and urine levels of HS6ST2 , CHPF2 and EXTL1 could help diagnose metastatic ccRCC. Genome-wide analysis of tissue samples from 481 ccRCC patients identified multiple genes involved...
BC Innovations | Mar 27, 2014
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Ovarian cancer Heparan sulfate 6-O-sulfotransferase 1 (HS6ST1); HS6ST2 In vitro and mouse studies suggest inhibiting HS6ST1 and HS6ST2 could help treat ovarian cancer. In human...
Items per page:
1 - 2 of 2